The effects of chronic renal failure and hemodialysis on human red and white cell calmodulin levels

A. D. Mooradian, John E. Morley, A. S. Levine, K. W. Korchik, H. S. Beyer, F. E. Kaiser, D. M. Brown

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Red blood cell (RBC) and polymorphonuclear white blood cell (WBC) calmodulin levels were measured in 25 uremic patients on regular hemodialysis. Uremic patients had significantly higher RBC [11.45 ± 0.66 (± SE) fg/cell] and WBC (590.5 ±110 fg/cell) calmodulin levels than normal subjects (8.62 ± 0.37 and 130 ± 30 fg/cell; P < 0.05). An extremely high RBC calmodulin level (20.58 fg/cell)was found in a patient with sickle cell anemia. Uremic patients on dialysis for 2 yr or more had lower RBC (10.99 ± 0.58 fg/cell) and WBC (390 ± 50 fg/ cell) calmodulin levels than those who were on dialysis for less than 2 yr (RBC, 12.30 ± 1.56 fg/cell; WBC, 943 ± 256 fg/cell; P < 0.05). There were no statistically significant differences in calmodulin levels when different subgroups of uremic patients were compared, e.g. patients with diabetes mellitus or those receiving supplemental vitamin D, anabolic steroids, or antihypertensive medications. We conclude that calmodulin levels are elevated in uremic patients on regular hemodialysis.

Original languageEnglish (US)
Pages (from-to)1010-1013
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume58
Issue number6
DOIs
StatePublished - Jun 1984

Fingerprint Dive into the research topics of 'The effects of chronic renal failure and hemodialysis on human red and white cell calmodulin levels'. Together they form a unique fingerprint.

Cite this